🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ProKidney Corp.
Market Cap: Medium
Employees: Low
Renal Autologous Cell Therapy
Pro Kidney Corp. is a clinical-stage biotechnology company focused on developing cellular therapy candidates, including Renal Autologous Cell Therapy, for the treatment of diabetic kidney disease and congenital anomalies of the kidney and urinary tract.
Symbol: PROK
Recent Price: $1.75
Industry: Biotechnology
CEO: Dr. Bruce Culleton M.D.
Sector: Healthcare
Employees: 163
Address: 2000 Frontis Plaza Blvd., Winston-Salem, NC 27103
Phone: 336 999 7028
Leadership
- Bruce Culleton, MD, Chief Executive Officer
- James Coulston, CPA, Chief Financial Officer
- Todd C. Girolamo, JD, MBA, Chief Legal Officer and Secretary
- Nikhil Pereira-Kamath, Chief Business Officer
- Darin J. Weber, PhD, Chief Regulatory Officer
- Carla Poulson, Chief People Officer
- Ulrich Ernst, PhD, EVP, Technical Operations
- Emily Butler, PhD, SVP, Biometrics
- Joseph Stavas, MD, MPH, SVP, Interventional Procedures and Patient Safety
- Lucio Tozzi, SVP, Global Clinical Operations
- Richard Williams, SVP, Information Technology
Last updated: 2024-12-31